VVA
Vida Ventures Advisors Portfolio holdings
AUM
$15.9M
This Quarter Return
+15.25%
1 Year Return
+52.49%
3 Year Return
+45.65%
5 Year Return
-49.37%
10 Year Return
–
AUM
$111M
AUM Growth
+$111M
(-5.8%)
Cap. Flow
-$16M
Cap. Flow
% of AUM
-14.33%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
3
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Dyne Therapeutics
DYN
|
$9.4M |
| 2 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$6.45M |
| 3 |
Q32 Bio
QTTB
|
$120K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Dyne Therapeutics
DYN
$1.92B
| $28.2M | 25.3% |
2,220,034
-740,012
| -25% | -$9.4M |
|
|
KNTE
2
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $26.4M | 23.68% |
2,207,772
-539,661
| -20% | -$6.45M |
|
3
Allogene Therapeutics
ALLO
$251M
| $19.4M | 17.43% |
1,798,163
| – | – |
|
|
CNTA
4
Centessa Pharmaceuticals
CNTA
$2.25B
| $15.8M | 14.18% |
3,931,818
| – | – |
|
|
KRON
5
DELISTED
Kronos Bio
KRON
| $9.26M | 8.31% |
2,765,314
| – | – |
|
6
Praxis Precision Medicines
PRAX
$958M
| $6.67M | 5.99% |
2,939,329
| – | – |
|
|
LIAN
7
DELISTED
LianBio American Depositary Shares
LIAN
| $4.56M | 4.1% |
2,282,084
| – | – |
|
|
8
Q32 Bio
QTTB
$20.9M
| $1.12M | 1.01% |
696,289
-74,556
| -10% | -$120K |
|